Colorectal Cancer is a significant health concern in Mauritius, ranking as the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths. It affects both men and women equally and is typically diagnosed around the age of 67. The majority of colorectal cancers develop from precancerous adenomas, making early detection crucial for prevention.
Colorectal Cancer Screening aims to identify precancerous lesions or cancer at an early, treatable stage, ultimately reducing mortality rates. Countries with established screening programs have seen notable declines in colorectal cancer diagnoses and related deaths.
To address this issue in Mauritius, we organized the Conference on Colorectal Cancer Screening, bringing together experts to discuss the implementation of a screening program. Following the conference, the National Committee on Bowel Cancer Screening was formed to develop a comprehensive screening pathway tailored to our population's needs.
Together, we are working diligently to establish a national colorectal cancer screening program, prioritizing early detection and improved outcomes for all individuals.
International Speakers
Dr Moreea
Consultant Gastroenterologist, Bradford University Hospital, UK
Professor Morris
Professor of Data Epidemiology, Nuffield Department of Population Health, University of Oxford
Professor Rutter
Professor of Gastroenterology, Newcastle University and University Hospital of North Tees, UK
Mrs Sally Benton
Consultant Clinical Scientist in Biochemistry and Clinical Lead for Routine Biochemistry at Berkshire and Surrey Pathology Services
Mrs Williamson
Lead Specialist Screening Practitioner for Bowel Cancer Screening, Tees Screening Centre
Mr Henson
Programme Manager for the Tees Bowel Cancer Screening Programme